isradipine has been researched along with Diabetic Angiopathies in 3 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rendell, MS | 1 |
Shehan, MA | 1 |
Kahler, K | 1 |
Bailey, KL | 1 |
Eckermann, AJ | 1 |
Byington, RP | 1 |
Furberg, CD | 1 |
Craven, TE | 1 |
Pahor, M | 1 |
Sowers, JR | 1 |
Mason, RP | 1 |
Mason, PE | 1 |
1 review available for isradipine and Diabetic Angiopathies
Article | Year |
---|---|
Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Diabetic Angiopathies; Humans; Hypertension; Isra | 1999 |
2 trials available for isradipine and Diabetic Angiopathies
Article | Year |
---|---|
Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers | 1997 |
Isradipine in prediabetic hypertensive subjects.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Dis | 1998 |